Transcriptional factor SP1 contributes to defence mechanism against treatment of irinotecan via promoting HB-EGF expression in ovarian clear cell  carcinoma.

k1501

WEKO3

lat lon distance

[[sub_check.contents]]

[[sub_radio.contents]]

Field does not validate

[[sub_attr.contents]]　

https://fukuoka-u.repo.nii.ac.jp/record/2427/files/k1501.pdf

内容の要旨及び結果の要旨

application/pdf

ファイル	ライセンス
k1501.pdf (351.1 kB) sha256 139c435c76a6f00282d1b6f18d450b63d121b05a6b7a61e26a1f09959a281732

Version	Date Modified	Object File Name	File Size	File Hash Value	Contributor Name	Show/Hide

Downloads

Plays